Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.22M
Expense Ratio	0.85%
PE Ratio	28.37
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.62%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	Semi-Annual
Payout Ratio	17.86%

Volume	704
Open	37.79
Previous Close	37.72
Day's Range	37.61 - 37.79
52-Week Low	31.08
52-Week High	42.41
Beta	1.07
Holdings	70
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

27.18% of assets

Name	Symbol	Weight
Synovus Financial Corp.	SNV	2.86%
ResMed Inc.	RMD	2.76%
Flutter Entertainment plc	FLUT	2.73%
The Charles Schwab Corporation	SCHW	2.72%
Royal Caribbean Cruises Ltd.	RCL	2.70%
Emerson Electric Co.	EMR	2.70%
Zillow Group, Inc.	Z	2.69%
Ferrari N.V.	RACE	2.68%
MasTec, Inc.	MTZ	2.68%
Sportradar Group AG	SRAD	2.66%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 4.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.65%.